Date | Title | Description | |
---|---|---|---|
26 Jul 2023 | On buy-back programmes | The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program. | Download |
10 May 2023 | On P&L | The Company releases the first quarter 2023 financial results presentation | Download |
10 May 2023 | On P&L | The Company releases the press release related to the first quarter 2023 financial results | Download |
25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download |
21 Feb 2023 | On business and financial situation | The Company releases the full year 2022 financial results presentation. | Download |
Pages
Date | Title | Description | |
---|---|---|---|
26 Feb 2020 | Annual Corporate Governance Report | ROVI releases the 2019 Annual Corporate Governance Report | Download |
26 Feb 2020 | Annual Report regarding remuneration of the members of the Board of Directors | ROVI releases the 2019 annual report regarding remuneration of the members of the Board of Directors | Download |
Pages
Date | Title | Description | |
---|---|---|---|
25 Jul 2017 | Otros sobre Gobierno Corporativo | The Company informes about the modification of the Internal code of conduct | Download |
10 Jul 2017 | Contratos de liquidez y contrapartida (2) | The Company informs that has signed a new liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. | Download |
10 Jul 2017 | Contratos de liquidez y contrapartida (1) | The Company informs that has cancelled the liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. | Download |
04 Jul 2017 | Contratos de liquidez y contrapartida | Liquidity contract: transactions conducted in the second quarter of 2017 | Download |
23 Jun 2017 | Información sobre dividendos | The Company informes about the dividends payment | Download |